Heterozygous mutations in PPARγ cause FPLD3 (OMIM 604367), clinically characterized by loss of subcutaneous limb and gluteal fat with preservation of visceral and subcutaneous abdominal fat, fatty infiltration of the liver, and hyperuricemia [14]. The gene discussed is PPARG; the disease is PPARG-related familial partial lipodystrophy.